Myeloid sarcoma: presentation, diagnosis, and treatment

LM Almond, M Charalampakis, SJ Ford… - … Myeloma and Leukemia, 2017 - Elsevier
Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. It is a rare
condition, most often associated with acute myeloid leukemia (AML), although in some rare …

Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: a tale of misnomers, controversy and the unresolved

RM Shallis, RP Gale, HM Lazarus, KB Roberts, ML Xu… - Blood reviews, 2021 - Elsevier
Abstract The World Health Organization classification and definition of “myeloid sarcoma” is
imprecise and misleading. A more accurate term is “extramedullary acute myeloid leukemia …

[HTML][HTML] The bone marrow microenvironment mechanisms in acute myeloid leukemia

DB Pimenta, VA Varela, TS Datoguia… - Frontiers in Cell and …, 2021 - frontiersin.org
Bone marrow (BM) is a highly complex tissue that provides important regulatory signals to
orchestrate hematopoiesis. Resident and transient cells occupy and interact with some well …

Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set

G Goyal, AC Bartley, MM Patnaik, MR Litzow… - Blood cancer …, 2017 - nature.com
Extramedullary myeloid sarcoma (MS, also known as granulocytic sarcoma, myeloblastoma
or chloroma) is a rare form (o1%) of extramedullary acute myeloid leukemia (AML) …

Myeloid sarcoma

OA Shahin, F Ravandi - Current opinion in hematology, 2020 - journals.lww.com
Myeloid sarcoma : Current Opinion in Hematology Myeloid sarcoma : Current Opinion in
Hematology Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts …

Clinicopathological characteristics of de novo and secondary myeloid sarcoma: a monocentric retrospective study

H Claerhout, S Van Aelst, C Melis… - European Journal of …, 2018 - Wiley Online Library
Objective Diagnosing myeloid sarcoma remains challenging, and we aimed to provide
clinicopathological features to facilitate diagnosis. Method Clinicopathological data from 41 …

Genomic analysis in myeloid sarcoma and comparison with paired acute myeloid leukemia

NY Greenland, JA Van Ziffle, YC Liu, Z Qi, S Prakash… - Human Pathology, 2021 - Elsevier
Myeloid sarcoma (MS) is a rare manifestation of acute myeloid leukemia (AML)
characterized by extramedullary proliferation of myeloid blasts. Owing to the rarity of MS, the …

Diagnostic and therapeutic considerations for extramedullary leukemia

R Bakst, A Powers, J Yahalom - Current Oncology Reports, 2020 - Springer
Abstract Purpose of Review The purpose of this review is to summarize the current literature
on the presentation, diagnosis, and treatment options available for extramedullary (EM) …

[HTML][HTML] Molecular discordance between myeloid sarcomas and concurrent bone marrows occurs in actionable genes and is associated with worse overall survival

B Werstein, J Dunlap, MJ Cascio, RS Ohgami… - The Journal of Molecular …, 2020 - Elsevier
Myeloid sarcoma is a rare, architecture-effacing proliferation of myeloid blasts localized to
an extramedullary site, with or without concurrent bone marrow involvement. Clonal …

Extramedullary acute myelogenous leukemia

M Solh, S Solomon, L Morris, K Holland, A Bashey - Blood reviews, 2016 - Elsevier
Extramedullary leukemia (EM AML), also known as myeloid sarcoma, is a rare manifestation
of acute myelogenous leukemia and often accompanies bone marrow involvement. EM AML …